AVAX Technologies, Inc. (AVXT) Files Form 10 With SEC
2/4/2011 11:20:30 AM
More...
|
AVAX Technologies, Inc. (AVXT) Closes Bridge Financing
12/17/2009 8:29:20 AM
More...
|
VasoGenix Pharmaceuticals, Inc. Elects Former AVAX Technologies, Inc. (AVXT) CEO Richard P. Rainey to Its Board of Directors
2/3/2009 11:24:37 AM
More...
|
AVAX Technologies, Inc. (AVXT) Announces Closing of Bridge Loan Financing
10/31/2008 11:25:39 AM
More...
|
AVAX Technologies, Inc. (AVXT) Presents Results of a Dose-Response Study of MVax(R) at American Society of Clinical Oncology
6/3/2008 2:37:20 PM
More...
|
AVAX Technologies, Inc. (AVXT) Announces Initiation of Clinical Study with Autologous Ovarian Cancer Vaccine (OVax(R))
4/9/2008 7:04:47 AM
More...
|
AVAX Technologies, Inc. (AVXT) Appoints Chief Medical Officer for EMEA
3/31/2008 9:02:33 AM
More...
|
AVAX Technologies, Inc. (AVXT) to Present Results of Phase I-II Study of MVax(R) at 2008 Meeting of the American Society of Clinical Oncology
3/24/2008 9:29:40 AM
More...
|
AVAX Technologies, Inc. (AVXT) Announces Successful Completion of Phase I / II Study of MVax(R) in Patients with Stage 3 and 4 Melanoma
12/11/2007 1:16:04 PM
More...
|
AVAX Technologies, Inc. (AVXT) Appoints Dr. Francois Martelet as President and Chief Executive Officer
12/4/2007 12:11:16 PM
More...
|
|